Automated Author ProfilePanaretakis, Theocharis
The University of Texas MD Anderson Cancer Center
Panaretakis, Theocharis
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 1.1 (sum of 4 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Additional file 2: Table S1. RNA sequencing raw data and analysis of enzalutamide-treated LNCaP cells versus untreated counterparts.
Authors
- Mourkioti, Ioanna ;
- Polyzou, Aikaterini ;
- Veroutis, Dimitris ;
- Theocharous, George ;
- Lagopati, Nefeli ;
- Gentile, Emanuela ;
- Stravokefalou, Vasiliki ;
- Thanos, Dimitris-Foivos ;
- Havaki, Sophia ;
- Kletsas, Dimitris ;
- Panaretakis, Theocharis ;
- Logothetis, Christopher J. ;
- Stellas, Dimitris ;
- Petty, Russell ;
- Blandino, Giovanni ;
- Papaspyropoulos, Angelos ;
- Gorgoulis, Vassilis G.
Additional file 2: Table S1. RNA sequencing raw data and analysis of enzalutamide-treated LNCaP cells versus untreated counterparts.
Authors
- Mourkioti, Ioanna ;
- Polyzou, Aikaterini ;
- Veroutis, Dimitris ;
- Theocharous, George ;
- Lagopati, Nefeli ;
- Gentile, Emanuela ;
- Stravokefalou, Vasiliki ;
- Thanos, Dimitris-Foivos ;
- Havaki, Sophia ;
- Kletsas, Dimitris ;
- Panaretakis, Theocharis ;
- Logothetis, Christopher J. ;
- Stellas, Dimitris ;
- Petty, Russell ;
- Blandino, Giovanni ;
- Papaspyropoulos, Angelos ;
- Gorgoulis, Vassilis G.
Additional file 3: Table S2. Pathway expression analysis of in vitro and in vivo enzalutamide-sensitive and –resistant prostate cancer samples. RNA sequencing data were retrieved from publically available datasets with accession numbers GSE55030, GSE109708, GSE184168, GSE163240, GSE150807 and GSE151083.
Authors
- Mourkioti, Ioanna ;
- Polyzou, Aikaterini ;
- Veroutis, Dimitris ;
- Theocharous, George ;
- Lagopati, Nefeli ;
- Gentile, Emanuela ;
- Stravokefalou, Vasiliki ;
- Thanos, Dimitris-Foivos ;
- Havaki, Sophia ;
- Kletsas, Dimitris ;
- Panaretakis, Theocharis ;
- Logothetis, Christopher J. ;
- Stellas, Dimitris ;
- Petty, Russell ;
- Blandino, Giovanni ;
- Papaspyropoulos, Angelos ;
- Gorgoulis, Vassilis G.
Additional file 3: Table S2. Pathway expression analysis of in vitro and in vivo enzalutamide-sensitive and –resistant prostate cancer samples. RNA sequencing data were retrieved from publically available datasets with accession numbers GSE55030, GSE109708, GSE184168, GSE163240, GSE150807 and GSE151083.
Authors
- Mourkioti, Ioanna ;
- Polyzou, Aikaterini ;
- Veroutis, Dimitris ;
- Theocharous, George ;
- Lagopati, Nefeli ;
- Gentile, Emanuela ;
- Stravokefalou, Vasiliki ;
- Thanos, Dimitris-Foivos ;
- Havaki, Sophia ;
- Kletsas, Dimitris ;
- Panaretakis, Theocharis ;
- Logothetis, Christopher J. ;
- Stellas, Dimitris ;
- Petty, Russell ;
- Blandino, Giovanni ;
- Papaspyropoulos, Angelos ;
- Gorgoulis, Vassilis G.